Hlupeni Admire, Liceralde Rayvlin John, Obisesan Adekunle, Tanoli Tariq
St Luke's Hospital, Internal Medicine Residency Department, Chesterfield, Missouri.
Midlands State University, Faculty of Medicine, Gweru, Zimbabwe.
AACE Endocrinol Diabetes. 2025 May 8;12(2):76-79. doi: 10.1016/j.aed.2025.05.001. eCollection 2025 Jul-Aug.
Severe hypoglycemia prompts emergent intervention, yet not all low glucose readings reflect true hypoglycemia. We present a striking case of extreme artifactual hypoglycemia due to high-dose vitamin C therapy, highlighting the diagnostic challenges and management implications.
A 76-year-old man with metastatic prostate cancer, receiving high-dose vitamin C as part of alternative therapy, presented with worsening malaise, oliguria, and edema. On presentation, despite critically low blood glucose (BG) reading (<20 mg/dL) on both point-of-care glucometer and laboratory testing, the patient remained asymptomatic. Repeated dextrose infusions failed to increase the recorded BG levels, contradicting the expected response in true hypoglycemia. Dialysis, rather than dextrose, ultimately corrected his BG readings. Additionally, his liver enzymes, initially undetectable on presentation, became measurable as dialysis progressed. Further investigation identified markedly elevated vitamin C levels as the interfering substance, affecting both standard glucose and liver enzyme assays, leading to pseudo-hypoglycemia.
This case highlights the impact of high-dose vitamin C on glucose oxidase-based assays, causing pseudohypoglycemia and potentially triggering inappropriate clinical interventions. Also, over-reliance on laboratory values without clinical correlation can be costly and problematic particularly in critically ill patients, emphasizing the need for contextual interpretation of biochemical data. Alternative glucose measurement methods, such as hexokinase assays, may be required in suspected cases.
Clinicians should suspect pseudohypoglycemia when glucose readings are critically low but the patient lacks corresponding symptoms, especially in patients pursuing alternative medicine. Whipple's Triad remains vital in differentiating true hypoglycemia from laboratory artifact, preventing unnecessary escalation of care.
严重低血糖需要紧急干预,但并非所有低血糖读数都反映真正的低血糖。我们报告了一例因大剂量维生素C治疗导致的极端人为低血糖的显著病例,突出了诊断挑战和管理意义。
一名76岁的转移性前列腺癌男性患者,接受大剂量维生素C作为替代疗法的一部分,出现不适加重、少尿和水肿。就诊时,尽管即时血糖仪和实验室检测的血糖(BG)读数极低(<20mg/dL),但患者仍无症状。反复输注葡萄糖未能提高记录的BG水平,这与真正低血糖的预期反应相矛盾。最终,透析而非葡萄糖纠正了他的BG读数。此外,他的肝酶在就诊时最初无法检测到,随着透析的进行变得可测量。进一步调查发现,显著升高的维生素C水平是干扰物质,影响标准葡萄糖和肝酶检测,导致假性低血糖。
该病例突出了大剂量维生素C对基于葡萄糖氧化酶的检测的影响,导致假性低血糖,并可能引发不适当的临床干预。此外,过度依赖实验室值而无临床相关性可能代价高昂且存在问题,特别是在重症患者中,强调了对生化数据进行背景解读的必要性。在疑似病例中可能需要采用替代的葡萄糖测量方法,如己糖激酶检测。
当血糖读数极低但患者缺乏相应症状时,临床医生应怀疑假性低血糖,尤其是在采用替代医学的患者中。惠普尔三联征在区分真正的低血糖与实验室假象方面仍然至关重要,可防止不必要的治疗升级。